Cargando…
Predictive value of the apolipoprotein B/A1 ratio in intracerebral hemorrhage outcomes
BACKGROUND AND AIMS: The apolipoprotein B (apoB)/apolipoprotein A1 (apoA1) ratio is a key indicator in predicting future cardiovascular outcomes. However, it is still unclear whether the ratio of apoB/apoA1 is a better predictor of the outcomes after intracerebral hemorrhage (ICH). Therefore, we aim...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279969/ https://www.ncbi.nlm.nih.gov/pubmed/35692081 http://dx.doi.org/10.1002/jcla.24562 |
_version_ | 1784746527490572288 |
---|---|
author | Alsamani, Rasha Limin, Zhang Jianwei, Wu Dan, Wang Yuehong, Sun Ziwei, Liu Huiwen, Xu Dongzhi, Wang Yijun, Shi Lingye, Qian Xingquan, Zhao Guojun, Zhang |
author_facet | Alsamani, Rasha Limin, Zhang Jianwei, Wu Dan, Wang Yuehong, Sun Ziwei, Liu Huiwen, Xu Dongzhi, Wang Yijun, Shi Lingye, Qian Xingquan, Zhao Guojun, Zhang |
author_sort | Alsamani, Rasha |
collection | PubMed |
description | BACKGROUND AND AIMS: The apolipoprotein B (apoB)/apolipoprotein A1 (apoA1) ratio is a key indicator in predicting future cardiovascular outcomes. However, it is still unclear whether the ratio of apoB/apoA1 is a better predictor of the outcomes after intracerebral hemorrhage (ICH). Therefore, we aimed to assess the relationships between the ratio of apoB/apoA1 and functional outcomes, all‐cause mortality, and stroke recurrence in ICH patients. METHODS: Two hundred and sixteen Chinese ICH patients participated in this study from December 2018 to December 2019. Laboratory routine tests including hematology analysis, coagulation tests, and lipid levels were examined. The clinical outcomes included functional outcomes evaluated by the modified Rankin Scale score (mRS), all‐cause death, and stroke recurrence 1 year after discharge. Associations between the apoB/apoA1 ratio and the outcomes were evaluated using logistic regression analysis. Based on multivariate analysis, we constructed a nomogram. Univariate survival analysis was performed by the Kaplan–Meier method and log‐rank test. All the patients were classified into two groups by the median value of the apoB/apoA1 ratio: B1 < 0.8 and B2 ≥ 0.8. RESULTS: Of the 216 patients, 107 had an apoB/apoA1 ratio ≥ 0.8. Eighty‐five patients had poor functional outcomes (mRS ≥ 3), and 32 patients had severe functional outcomes (mRS ≥ 4). During the 1‐year follow‐up, a total of 18 patients died, and 13 patients had apoB/apoA1 ratio levels ≥0.8 during the 1‐year follow‐up period. Moreover, 16 recurrent strokes were recorded. Adjustments for age, sex, smoking, alcohol, body mass index, lipid levels, and hematoma site and volume showed that a high apoB/apoA1 ratio was significantly related to adverse functional outcomes and all‐cause mortality. The ORs for B2 versus B1 were 3.76 (95% CI: 1.37 to 10.40, p = 0.010), 22.74 (95% CI: 1.08 to 474.65, p = 0.044), and 7.23 (95% CI: 1.28 to 40.88, p = 0.025) for poor functional outcomes with mRS ≥ 3, mRS ≥ 4, and all‐cause mortality, respectively. CONCLUSION: An increased apoB/apoA1 ratio at admission was independently related to poor functional outcome and all‐cause mortality in ICH patients at the 1‐year follow‐up. |
format | Online Article Text |
id | pubmed-9279969 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-92799692022-07-15 Predictive value of the apolipoprotein B/A1 ratio in intracerebral hemorrhage outcomes Alsamani, Rasha Limin, Zhang Jianwei, Wu Dan, Wang Yuehong, Sun Ziwei, Liu Huiwen, Xu Dongzhi, Wang Yijun, Shi Lingye, Qian Xingquan, Zhao Guojun, Zhang J Clin Lab Anal Research Articles BACKGROUND AND AIMS: The apolipoprotein B (apoB)/apolipoprotein A1 (apoA1) ratio is a key indicator in predicting future cardiovascular outcomes. However, it is still unclear whether the ratio of apoB/apoA1 is a better predictor of the outcomes after intracerebral hemorrhage (ICH). Therefore, we aimed to assess the relationships between the ratio of apoB/apoA1 and functional outcomes, all‐cause mortality, and stroke recurrence in ICH patients. METHODS: Two hundred and sixteen Chinese ICH patients participated in this study from December 2018 to December 2019. Laboratory routine tests including hematology analysis, coagulation tests, and lipid levels were examined. The clinical outcomes included functional outcomes evaluated by the modified Rankin Scale score (mRS), all‐cause death, and stroke recurrence 1 year after discharge. Associations between the apoB/apoA1 ratio and the outcomes were evaluated using logistic regression analysis. Based on multivariate analysis, we constructed a nomogram. Univariate survival analysis was performed by the Kaplan–Meier method and log‐rank test. All the patients were classified into two groups by the median value of the apoB/apoA1 ratio: B1 < 0.8 and B2 ≥ 0.8. RESULTS: Of the 216 patients, 107 had an apoB/apoA1 ratio ≥ 0.8. Eighty‐five patients had poor functional outcomes (mRS ≥ 3), and 32 patients had severe functional outcomes (mRS ≥ 4). During the 1‐year follow‐up, a total of 18 patients died, and 13 patients had apoB/apoA1 ratio levels ≥0.8 during the 1‐year follow‐up period. Moreover, 16 recurrent strokes were recorded. Adjustments for age, sex, smoking, alcohol, body mass index, lipid levels, and hematoma site and volume showed that a high apoB/apoA1 ratio was significantly related to adverse functional outcomes and all‐cause mortality. The ORs for B2 versus B1 were 3.76 (95% CI: 1.37 to 10.40, p = 0.010), 22.74 (95% CI: 1.08 to 474.65, p = 0.044), and 7.23 (95% CI: 1.28 to 40.88, p = 0.025) for poor functional outcomes with mRS ≥ 3, mRS ≥ 4, and all‐cause mortality, respectively. CONCLUSION: An increased apoB/apoA1 ratio at admission was independently related to poor functional outcome and all‐cause mortality in ICH patients at the 1‐year follow‐up. John Wiley and Sons Inc. 2022-06-12 /pmc/articles/PMC9279969/ /pubmed/35692081 http://dx.doi.org/10.1002/jcla.24562 Text en © 2022 The Authors. Journal of Clinical Laboratory Analysis published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Research Articles Alsamani, Rasha Limin, Zhang Jianwei, Wu Dan, Wang Yuehong, Sun Ziwei, Liu Huiwen, Xu Dongzhi, Wang Yijun, Shi Lingye, Qian Xingquan, Zhao Guojun, Zhang Predictive value of the apolipoprotein B/A1 ratio in intracerebral hemorrhage outcomes |
title | Predictive value of the apolipoprotein B/A1 ratio in intracerebral hemorrhage outcomes |
title_full | Predictive value of the apolipoprotein B/A1 ratio in intracerebral hemorrhage outcomes |
title_fullStr | Predictive value of the apolipoprotein B/A1 ratio in intracerebral hemorrhage outcomes |
title_full_unstemmed | Predictive value of the apolipoprotein B/A1 ratio in intracerebral hemorrhage outcomes |
title_short | Predictive value of the apolipoprotein B/A1 ratio in intracerebral hemorrhage outcomes |
title_sort | predictive value of the apolipoprotein b/a1 ratio in intracerebral hemorrhage outcomes |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279969/ https://www.ncbi.nlm.nih.gov/pubmed/35692081 http://dx.doi.org/10.1002/jcla.24562 |
work_keys_str_mv | AT alsamanirasha predictivevalueoftheapolipoproteinba1ratioinintracerebralhemorrhageoutcomes AT liminzhang predictivevalueoftheapolipoproteinba1ratioinintracerebralhemorrhageoutcomes AT jianweiwu predictivevalueoftheapolipoproteinba1ratioinintracerebralhemorrhageoutcomes AT danwang predictivevalueoftheapolipoproteinba1ratioinintracerebralhemorrhageoutcomes AT yuehongsun predictivevalueoftheapolipoproteinba1ratioinintracerebralhemorrhageoutcomes AT ziweiliu predictivevalueoftheapolipoproteinba1ratioinintracerebralhemorrhageoutcomes AT huiwenxu predictivevalueoftheapolipoproteinba1ratioinintracerebralhemorrhageoutcomes AT dongzhiwang predictivevalueoftheapolipoproteinba1ratioinintracerebralhemorrhageoutcomes AT yijunshi predictivevalueoftheapolipoproteinba1ratioinintracerebralhemorrhageoutcomes AT lingyeqian predictivevalueoftheapolipoproteinba1ratioinintracerebralhemorrhageoutcomes AT xingquanzhao predictivevalueoftheapolipoproteinba1ratioinintracerebralhemorrhageoutcomes AT guojunzhang predictivevalueoftheapolipoproteinba1ratioinintracerebralhemorrhageoutcomes |